Marrone Bio Innovations Inc. (MBII) Upgraded to “Hold” by Zacks Investment Research
Marrone Bio Innovations Inc. (NASDAQ:MBII) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday.
According to Zacks, “Marrone Bio Innovations Inc. develops environmentally safe bio-based products. The Company specializes in the discovery, development, and marketing of natural products for weed, pest, water resource, and plant disease management. It offers crop protection products for conventional and organic crop production, including herbicides for weed control, fungicides for plant disease control, nematicides for parasitic roundworm control, insecticides for insect and mite killers and plant growth regulators that growers use to increase crop yields, enhance plant health, manage pest resistance, and reduce chemical residues. Marrone Bio Innovations Inc. is headquartered in Davis, California. “
Marrone Bio Innovations (NASDAQ:MBII) opened at 1.67 on Wednesday. The firm’s 50 day moving average price is $1.61 and its 200-day moving average price is $1.03. Marrone Bio Innovations has a 52 week low of $0.60 and a 52 week high of $3.76. The firm’s market cap is $41.11 million.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/12/marrone-bio-innovations-inc-mbii-upgraded-to-hold-by-zacks-investment-research.html
Marrone Bio Innovations (NASDAQ:MBII) last posted its earnings results on Tuesday, August 9th. The company reported ($0.28) EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.28). The firm had revenue of $5 million for the quarter, compared to the consensus estimate of $4.61 million. Marrone Bio Innovations had a negative net margin of 304.71% and a negative return on equity of 2,083.14%. On average, analysts forecast that Marrone Bio Innovations will post ($1.12) EPS for the current year.
About Marrone Bio Innovations
Marrone Bio Innovations, Inc offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Marrone Bio Innovations Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marrone Bio Innovations Inc. and related companies with MarketBeat.com's FREE daily email newsletter.